Some, however, should avoid semaglutide, particularly those with thyroid cancer histories or gastrointestinal issues
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Use examples: short elective scope after four weeks off and major abdominal surgery after six to eight weeks off
It is injected once a week Tirzepatide: A combination of GLP-1 and GIP agonists
At this pricing, effective medical weight loss is accessible to more patients
While they share similar gastrointestinal side effects, tirzepatide targets two hormone receptors instead of one, which may influence how individual patients tolerate the medication